The Indian Council of Medical Research (ICMR) marked a significant milestone on May 25 by facilitating the transfer of 41 public-health technologies to various industry partners. This event, recognized as the largest of its kind in India, aims to bridge the gap between laboratory research and practical healthcare applications. By handing over these indigenous innovations, the council seeks to address urgent public health priorities through scalable commercial production.
This initiative falls under the ICMR Medical Innovation Patent Mitra program, a structured platform designed to showcase biomedical breakthroughs. The Ministry of Health and Family Welfare stated that the primary goal is to translate local research into accessible solutions. These technologies span a wide range of medical needs, from advanced diagnostics to life-saving vaccines and specialized medical devices.
- Typhoid and Paratyphoid vaccines — including recombinant and glycoconjugate variants for widespread immunization
- Diagnostic kits for critical diseases — covering Japanese Encephalitis, Tuberculosis, and Mpox detection
- Biomedical Patent Landscape Report — a new document released to guide intellectual property strategy
During the event, Prataprao Ganpatrao Jadhav, the Union Minister of State for Ayush and Health, emphasized the importance of connecting science with industry. He remarked, "This initiative marks a decisive step in ensuring that innovations developed in our laboratories translate into technologies that strengthen public health." Jadhav noted that India is evolving from a consumer of health tech into a global hub for affordable medical solutions.
Dr. Gobardhan Das, a member of NITI Aayog, highlighted that the Medical Innovation Patent Mitra would be vital in protecting intellectual property. He believes the country possesses the scientific depth required to lead the global health technology sector. To support this vision, the Technology Compendium was unveiled to provide a roadmap for future technology transfers and ecosystem growth.
More than 100 technologies developed by ICMR institutes, startups, and independent researchers were showcased during the facilitation. These innovations represent a diverse array of therapeutics and medical devices ready for market integration. The collaborative effort between government bodies and private industry is expected to significantly accelerate the journey of indigenous medical solutions from the lab to the general public.
